Prescription for American Drug Independence Act of 2020
Latest action · May 1, 2020 Referred to the House Committee on Energy and Commerce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 1, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Prescription for American Drug Independence Act of 2020
This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) establish a committee of experts on drug-supply issues, (2) convene a symposium to recommend strategies for ending U.S. dependence on foreign manufacturing of critical drugs, and (3) report on the symposium's proceedings.
Cosponsors 7
Members who signed on, in the order they did. Signatures ran from May 1, 2020 to Jul 9, 2020; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-IN | Susan W. Brooks | Original | May 1, 2020 |
| R-FL | Bill Posey | May 12, 2020 | |
| D-OH | Tim Ryan | May 12, 2020 | |
| R-OH | Robert E. Latta | Jun 8, 2020 | |
| D-OK | Kendra S. Horn | Jun 18, 2020 | |
| R-WA | Jaime Herrera Beutler | Jun 29, 2020 | |
| D-PA | Matt Cartwright | Jul 9, 2020 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 1, 2020 |
Actions 2
Everything that happened, newest first.
- May 1, 2020Introduced in House
- May 1, 2020Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 82, May 1, 2020, page H1973.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46507 | FDA’s Role in the Medical Product Supply Chain and Considerations During COVID-19 Archived | Report | Sep 1, 2020 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 6800 | The Heroes Act | Related bill | Jul 23, 2020 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To provide for an exploration of strategies to increase domestic manufacturing and diversify the supply chain of critical drugs, and for other purposes.
- Short Title(s) as Introduced
- Prescription for American Drug Independence Act of 2020
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- May 1, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.